In the TCGA-STAD cohort, CPNE8 expression was positively correlated with the expression of immune checkpoint genes such as PDCD1LG2, HAVCR2, and TIGIT, suggesting that higher CPNE8 expression may predict poorer immune responses in GC patients (Figure 7C). The gene discussed is HAVCR2; the disease is gastric cancer.